Navigation Links
Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
Date:11/10/2011

CRANBURY, N.J., Nov. 10, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its first quarter, fiscal year 2012 financial results on Tuesday, November 15, 2011 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 15, 2011, which will include discussion of the results of operations in greater detail and an update on corporate developments.Schedule for the Financial Results Press Release, Conference Call / Webcast-
Q1 Fiscal Year 2012 Financial Results Press Release11/15/2011 at 7:30 a.m. ET-
Q1 Fiscal Year 2012 Conference Call-Live

11/15/2011 at 11:00 a.m. ETDomestic Dial-In Number

1-888-256-1007International Dial-In Number

1-913-312-1466Pass code

3249586-
Q1 Fiscal Year 2012 Conference Call-Replay

11/15-11/22/2011Domestic Dial-In Number

1-888-203-1112International Dial-In Number

1-719-457-0820Pass code

3249586-
Webcast Live and Replay Access

http://www.palatin.comThe webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts"

section of Palatin's website at http://www.palatin.comAbout Palatin Technologies, Inc.Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.

Palatin Technologies Investor Inquiries:Palatin Technologies Media Inquiries:Stephen T. Wills, CPA, MST

Carney Noensie, Burns McClellanChief Operating Officer / Chief Financial OfficerVice President, Investor RelationsTel: (609) 495-2200 / info@palatin.com

Tel: (212) 213-0006 / cnoensie@burnsmc.com
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies to Present at 10th Annual BIO Investor Forum
2. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
3. Palatin Technologies, Inc. to Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011
4. Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
6. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
7. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
8. Palatin Technologies, Inc. Announces Results of Annual Stockholders Meeting
9. Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
10. Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
11. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2019)... Calif. (PRWEB) , ... January 02, 2019 , ... ... proprietary technology to detect precancer and cancer cells in blood, has been named ... Biotech , a global biotech company developing cell therapies for cancer treatment, will ...
(Date:12/19/2018)... VEGAS (PRWEB) , ... December 19, 2018 , ... ... aesthetics procedures at its first rate Stem Cell Training Course in Las Vegas. ... and women. As regenerative procedures explode in popularity nationwide for aesthetics, having the ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, the leading ... industry, unveiled a completely redesigned website at http://www.usdm.com . The site offers ... their valued clients and business partners. , The website has a revamped ...
(Date:12/13/2018)... WORCESTER, Mass. (PRWEB) , ... December 11, 2018 ... ... a biosensor that doctors and nurses can use to quickly detect Clostridium difficile ... to be the heart of a handheld device that can be used onsite ...
Breaking Biology Technology:
(Date:12/13/2018)... ... December 12, 2018 , ... ... of regenerative cellular therapy, has announced the launch of Maxx-Cell, the world's most ... gold standard approach of aspirating a patients autologous bone marrow cells. Maxx™-Cell however ...
(Date:12/10/2018)... ... December 10, 2018 , ... Nanomedical Diagnostics , ... headquarters relocation to 9640 Towne Centre Drive, Suite 100, effectively tripling its space from ... both domestically and internationally, for the sales of our drug discovery platforms. We’re in ...
(Date:12/5/2018)... ... December 05, 2018 , ... Dr. Nicolas Loebel was a ... England. The 2018 PDT symposium was organized by the RSM Professionals, UK PDT ... clinical practice across a range of applications in oncology and infection treatment and ...
Breaking Biology News(10 mins):